These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 38267285)

  • 1. Percutaneous left atrial appendage occlusion in mitral valve disease: A Nationwide Readmission Database analysis.
    Feroze R; Ullah W; Kang P; Lobo T; Alhabdan N; Alghammass M; Yoon SH; Dallan LAP; Filby SJ
    Cardiovasc Revasc Med; 2024 Jun; 63():23-30. PubMed ID: 38267285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left Atrial Appendage Occlusion in Patients With Anticoagulation Failure vs Anticoagulation Contraindication.
    Aarnink EW; Maarse M; Fierro N; Mazzone P; Beneduce A; Tondo C; Gasperetti A; Pracon R; Demkow M; Zieliński K; de Backer O; Korsholm K; Nielsen-Kudsk JE; Estévez-Loureiro R; Caneiro-Queija B; Benito-González T; Pérez de Prado A; Nombela-Franco L; Salinas P; Holmes D; Almakadma AH; Berti S; Romeo MR; Millan X; Arzamendi D; Alla VM; Agarwal H; Eitel I; Paitazoglou C; Freixa X; Cepas-Guillén P; Chothia R; Badejoko SO; Spoon DB; Maddux JT; El-Chami M; Ram P; Branca L; Adamo M; Suradi HS; Peper J; van Dijk VF; Rensing BJWM; Swaans MJ; Vireca E; Bergmann MW; Boersma LVA;
    JACC Cardiovasc Interv; 2024 Jun; 17(11):1311-1321. PubMed ID: 38795093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percutaneous left atrial appendage occlusion: A review of current devices, clinical evidence, patient selection, and post procedural antithrombotic management.
    Jackson LR; Jackson KP; Thomas KL
    Prog Cardiovasc Dis; 2021; 66():92-100. PubMed ID: 34332665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of atrial myopathy in mitral valve disease on safety outcomes in left atrial appendage closure.
    Kany S; Skibowski J; Müller CH; Geist V; Schmitt J; Niroomand F; Hailer B; Pleger S; Akin I; Hochadel M; Senges J; Lubos E
    Clin Res Cardiol; 2023 Jun; 112(6):824-833. PubMed ID: 36739561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes and predictors of readmission after implantation of a percutaneous left atrial appendage occlusion device in the United States: A propensity score-matched analysis from The National Readmission Database.
    Pasupula DK; Munir MB; Bhat AG; Siddappa Malleshappa SK; Meera SJ; Spooner M; Koranne K; Olshansky B; Hirji S; Hsu JC
    J Cardiovasc Electrophysiol; 2021 Nov; 32(11):2961-2970. PubMed ID: 34535939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilization and adverse outcomes of percutaneous left atrial appendage closure for stroke prevention in atrial fibrillation in the United States: influence of hospital volume.
    Badheka AO; Chothani A; Mehta K; Patel NJ; Deshmukh A; Hoosien M; Shah N; Singh V; Grover P; Savani GT; Panaich SS; Rathod A; Patel N; Arora S; Bhalara V; Coffey JO; O'Neill W; Makkar R; Grines CL; Schreiber T; Di Biase L; Natale A; Viles-Gonzalez JF
    Circ Arrhythm Electrophysiol; 2015 Feb; 8(1):42-8. PubMed ID: 25480543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left atrial appendage occlusion with the Amplatzer Cardiac Plug could improve survival and prevent thrombo-embolic and major bleeding events in atrial fibrillation patients with increased bleeding risk.
    Budts W; Laenens D; Van Calenbergh F; Vermeersch P; De Potter T; Aminian A; Benit E; Stammen F; Kefer J
    Acta Cardiol; 2016 Apr; 71(2):135-43. PubMed ID: 27090034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stroke Prevention With Prophylactic Left Atrial Appendage Occlusion in Cardiac Surgery Patients Without Atrial Fibrillation: A Meta-Analysis of Randomized and Propensity-Score Studies.
    Baudo M; Sicouri S; Yamashita Y; Senzai M; McCarthy PM; Gerdisch MW; Whitlock RP; Ramlawi B
    Circ Cardiovasc Interv; 2024 Oct; 17(10):e014296. PubMed ID: 39258365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Between Left Atrial Appendage Occlusion and Readmission for Thromboembolism Among Patients With Atrial Fibrillation Undergoing Concomitant Cardiac Surgery.
    Friedman DJ; Piccini JP; Wang T; Zheng J; Malaisrie SC; Holmes DR; Suri RM; Mack MJ; Badhwar V; Jacobs JP; Gaca JG; Chow SC; Peterson ED; Brennan JM
    JAMA; 2018 Jan; 319(4):365-374. PubMed ID: 29362794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unconventional combination of left atrial appendage device occlusion in patients with atrial fibrillation who needed concomitant catheter interventions for underlying structural heart disease.
    Raghuram P; Pavithran S; Sivakumar K
    Indian Heart J; 2020; 72(5):369-375. PubMed ID: 33189196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined atrial fibrillation ablation and left atrial appendage occlusion procedure in the United States: a propensity score matched analysis from 2016-2019 national readmission database.
    Pasupula DK; Siddappa Malleshappa SK; Munir MB; Bhat AG; Anandaraj A; Jakkoju A; Spooner M; Koranne K; Hsu JC; Olshansky B; Camm AJ
    Europace; 2023 Feb; 25(2):390-399. PubMed ID: 36350997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An under-recognized high-risk atrial fibrillation population: Analyzing transcatheter mitral valve repair patients for left atrial appendage closure device application.
    Lane CE; Eleid MF; Holmes DR
    Catheter Cardiovasc Interv; 2019 Aug; 94(2):274-279. PubMed ID: 30953408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Propensity-Matched Comparison of Oral Anticoagulation Versus Antiplatelet Therapy After Left Atrial Appendage Closure With WATCHMAN.
    Søndergaard L; Wong YH; Reddy VY; Boersma LVA; Bergmann MW; Doshi S; Kar S; Sievert H; Wehrenberg S; Stein K; Holmes DR
    JACC Cardiovasc Interv; 2019 Jun; 12(11):1055-1063. PubMed ID: 31171282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thromboembolic events and need for anticoagulation therapy following left atrial appendage occlusion in patients with electrical isolation of the appendage.
    Gadiyaram VK; Mohanty S; Gianni C; Trivedi C; Al-Ahmad A; Burkhardt DJ; Gallinghouse JG; Hranitzky PM; Horton RP; Sanchez JE; Della Rocca DG; Di Biase L; Price MJ; Couts L; Gibson D; Natale A
    J Cardiovasc Electrophysiol; 2019 Apr; 30(4):511-516. PubMed ID: 30623500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Operator Experience and Outcomes after Transcatheter Left Atrial Appendage Occlusion with the Watchman Device.
    Sawant AC; Seibolt L; Sridhara S; Rodriguez J; Distler E; Murarka S; Lazkani M; Kumar A; Kanwar N; Prakash MPH; Wiesner P; Pershad A
    Cardiovasc Revasc Med; 2020 Apr; 21(4):467-472. PubMed ID: 31501020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Head-to-head comparison between left atrial appendage occlusion and non-vitamin K oral anticoagulants in non-valvular atrial fibrillation patients: A systematic review and meta-analysis study.
    Waranugraha Y; Lin LY; Tsai CT
    Trends Cardiovasc Med; 2024 May; 34(4):225-233. PubMed ID: 36775218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes With the WATCHMAN FLX in Everyday Clinical Practice From the NCDR Left Atrial Appendage Occlusion Registry.
    Kapadia SR; Yeh RW; Price MJ; Piccini JP; Nair DG; Bansal A; Hsu JC; Freeman JV; Christen T; Allocco DJ; Gibson DN
    Circ Cardiovasc Interv; 2024 Sep; 17(9):e013750. PubMed ID: 39056187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous left atrial appendage occlusion using different technologies in the United Kingdom: A multicenter registry.
    Betts TR; Leo M; Panikker S; Kanagaratnam P; Koa-Wing M; Davies DW; Hildick-Smith D; Wynne DG; Ormerod O; Segal OR; Chow AW; Todd D; Cabrera Gomez S; Kirkwood GJ; Fox D; Pepper C; Foran J; Wong T
    Catheter Cardiovasc Interv; 2017 Feb; 89(3):484-492. PubMed ID: 27651124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Periprocedural Pericardial Effusion Complicating Transcatheter Left Atrial Appendage Occlusion: A Report From the NCDR LAAO Registry.
    Price MJ; Valderrábano M; Zimmerman S; Friedman DJ; Kar S; Curtis JP; Masoudi FA; Freeman JV
    Circ Cardiovasc Interv; 2022 May; 15(5):e011718. PubMed ID: 35369701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and causes of in-hospital outcomes and 30-day readmissions after percutaneous left atrial appendage closure: A US nationwide retrospective cohort study using claims data.
    Vuddanda VLK; Turagam MK; Umale NA; Shah Z; Lakkireddy DR; Bartus K; McCausland FR; Velagapudi P; Mansour M; Heist EK
    Heart Rhythm; 2020 Mar; 17(3):374-382. PubMed ID: 31539630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.